Cargando…

Nrf2 Pathway in Huntington’s Disease (HD): What Is Its Role?

Huntington’s disease (HD) is an autosomal dominant neurodegenerative disease that occurs worldwide. Despite some progress in understanding the onset of HD, drugs that block or delay symptoms are still not available. In recent years, many treatments have been proposed; among them, nuclear transcripti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tucci, Paolo, Lattanzi, Roberta, Severini, Cinzia, Saso, Luciano
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9739588/ https://www.ncbi.nlm.nih.gov/pubmed/36499596 http://dx.doi.org/10.3390/ijms232315272

Ejemplares similares

The Role of the NRF2 Pathway in Maintaining and Improving Cognitive Function
por: Gray, Nora E., et al.
Publicado: (2022)

The Role of Prokineticin 2 in Oxidative Stress and in Neuropathological Processes
por: Lattanzi, Roberta, et al.
Publicado: (2021)

A Perspective on Nrf2 Signaling Pathway for Neuroinflammation: A Potential Therapeutic Target in Alzheimer's and Parkinson's Diseases
por: Saha, Sarmistha, et al.
Publicado: (2022)

An Overview of Nrf2 Signaling Pathway and Its Role in Inflammation
por: Saha, Sarmistha, et al.
Publicado: (2020)

A Pivotal Role of Nrf2 in Neurodegenerative Disorders: A New Way for Therapeutic Strategies
por: Suzen, Sibel, et al.
Publicado: (2022)

Disease Burden of Huntington’s Disease (HD) on People Living with HD and Care Partners in Canada
por: Shaw, Eileen, et al.
Publicado: (2022)

Refining the diagnosis of Huntington disease: the PREDICT-HD study
por: Biglan, Kevin M., et al.
Publicado: (2013)

Molecule of the month: miRNA and Huntington's disease (HD)
por: Shapshak, Paul
Publicado: (2013)

NRF2 Activation by Nitrogen Heterocycles: A Review
por: Egbujor, Melford C., et al.
Publicado: (2023)

Detection of Huntington’s disease decades before diagnosis: the Predict-HD study
por: Paulsen, J S, et al.
Publicado: (2008)

Compensation in Preclinical Huntington's Disease: Evidence From the Track-On HD Study
por: Klöppel, Stefan, et al.
Publicado: (2015)

Memantine Use and Cognitive Decline in Huntington's Disease: An Enroll‐HD Study
por: Ogilvie, Amy C., et al.
Publicado: (2023)

Prevalence of neurocognitive disorder in Huntington’s disease using the Enroll-HD dataset
por: Sierra, Luis A., et al.
Publicado: (2023)

Regulatory Role of Nrf2 Signaling Pathway in Wound Healing Process
por: Süntar, Ipek, et al.
Publicado: (2021)

Potential Clinical Role of Prokineticin 2 (PK2) in Neurodegenerative Diseases
por: Maftei, Daniela, et al.
Publicado: (2022)

Decreased Striatal RGS2 Expression Is Neuroprotective in Huntington's Disease (HD) and Exemplifies a Compensatory Aspect of HD-Induced Gene Regulation
por: Seredenina, Tamara, et al.
Publicado: (2011)

Multivariate prediction of motor diagnosis in Huntington's disease: 12 years of PREDICT‐HD
por: Long, Jeffrey D., et al.
Publicado: (2015)

MicroRNAs in CSF as prodromal biomarkers for Huntington disease in the PREDICT-HD study
por: Reed, Eric R., et al.
Publicado: (2018)

Exploring the predictors of financial impairment in Huntington’s disease using the Enroll-HD dataset
por: Harris, Kate L., et al.
Publicado: (2022)

Stem Cells for Huntington’s Disease (SC4HD): An International Consortium to Facilitate Stem Cell-Based Therapy for Huntington’s Disease
Publicado: (2021)

Therapeutic Targeting of the NRF2 Signaling Pathway in Cancer
por: Telkoparan-Akillilar, Pelin, et al.
Publicado: (2021)

The Nrf2 Pathway in Ischemic Stroke: A Review
por: Farina, Marcelo, et al.
Publicado: (2021)

Tetrabenazine as anti-chorea therapy in Huntington Disease: an open-label continuation study. Huntington Study Group/TETRA-HD Investigators
por: Frank, Samuel
Publicado: (2009)

Volumetric Analysis of the Hypothalamus in Huntington Disease Using 3T MRI: The IMAGE-HD Study
por: Gabery, Sanaz, et al.
Publicado: (2015)

Accuracy of automated amygdala MRI segmentation approaches in Huntington's disease in the IMAGE‐HD cohort
por: Alexander, Bonnie, et al.
Publicado: (2020)

Enroll-HD: An Integrated Clinical Research Platform and Worldwide Observational Study for Huntington's Disease
por: Sathe, Swati, et al.
Publicado: (2021)

Another Perspective on Huntington’s Disease: Disease Burden in Family Members and Pre-Manifest HD When Compared to Genotype-Negative Participants from ENROLL-HD
por: Achenbach, Jannis, et al.
Publicado: (2021)

The Role of Organosulfur Compounds as Nrf2 Activators and Their Antioxidant Effects
por: Egbujor, Melford Chuka, et al.
Publicado: (2022)

Huntington's Disease and its therapeutic target genes: a global functional profile based on the HD Research Crossroads database
por: Kalathur, Ravi Kiran Reddy, et al.
Publicado: (2012)

Increased Body Weight of the BAC HD Transgenic Mouse Model of Huntington’s Disease Accounts for Some but Not All of the Observed HD-like Motor Deficits
por: Kudwa, Andrea E., et al.
Publicado: (2013)

Myelinosome Organelles in the Retina of R6/1 Huntington Disease (HD) Mice: Ubiquitous Distribution and Possible Role in Disease Spreading
por: Yefimova, Marina G., et al.
Publicado: (2021)

HD-PRO-TRIAD™ Validation: A Patient-reported Instrument for the Symptom Triad of Huntington's Disease
por: Carlozzi, Noelle E., et al.
Publicado: (2014)

Striatal morphology correlates with frontostriatal electrophysiological motor processing in Huntington's disease: an IMAGE‐HD study
por: Turner, Lauren M., et al.
Publicado: (2016)

Reduced amygdala volumes are related to motor and cognitive signs in Huntington's disease: The IMAGE-HD study
por: Ahveninen, Lotta M., et al.
Publicado: (2018)

The Clinical Picture of Psychosis in Manifest Huntington's Disease: A Comprehensive Analysis of the Enroll-HD Database
por: Rocha, Natalia P., et al.
Publicado: (2018)

Antidopaminergic treatment is associated with reduced chorea and irritability but impaired cognition in Huntington’s disease (Enroll-HD)
por: Harris, Kate L, et al.
Publicado: (2020)

Investigating longitudinal changes to frontal cortico-striatal tracts in Huntington’s disease: the IMAGE-HD study
por: Tan, Brendan, et al.
Publicado: (2022)

Full Remission of Obsessive Compulsive Disorder (OCD) Symptoms in Huntington's Disease (HD) Using Fluoxetine
por: Devasia, Mithun, et al.
Publicado: (2023)

Machine learning in Huntington’s disease: exploring the Enroll-HD dataset for prognosis and driving capability prediction
por: Ouwerkerk, Jasper, et al.
Publicado: (2023)

HD_BPMDS: a curated binary pattern multitarget dataset of Huntington’s disease–targeting agents
por: Stefan, Sven Marcel, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_7ooj5jqbde8dc8hf4jskdcis2m